PolyPid Ltd.
Index- P/E- EPS (ttm)-2.43 Insider Own21.38% Shs Outstand19.60M Perf Week-20.11%
Market Cap16.58M Forward P/E- EPS next Y-0.86 Insider Trans0.00% Shs Float15.48M Perf Month7.25%
Income-46.50M PEG- EPS next Q-0.41 Inst Own12.80% Short Float / Ratio3.52% / 1.48 Perf Quarter-17.25%
Sales- P/S- EPS this Y-8.00% Inst Trans-17.70% Short Interest0.55M Perf Half Y-84.50%
Book/sh0.59 P/B1.33 EPS next Y4.10% ROA-129.20% Target Price3.38 Perf Year-82.79%
Cash/sh0.85 P/C0.92 EPS next 5Y- ROE-194.90% 52W Range0.65 - 6.90 Perf YTD12.24%
Dividend- P/FCF- EPS past 5Y-22.60% ROI- 52W High-88.65% Beta-
Dividend %- Quick Ratio2.90 Sales past 5Y- Gross Margin- 52W Low20.45% ATR0.11
Employees75 Current Ratio2.90 Sales Q/Q- Oper. Margin- RSI (14)44.99 Volatility19.45% 12.24%
OptionableYes Debt/Eq1.00 EPS Q/Q10.70% Profit Margin- Rel Volume0.89 Prev Close0.83
ShortableYes LT Debt/Eq0.73 EarningsNov 09 BMO Payout- Avg Volume368.03K Price0.78
Recom2.20 SMA20-7.16% SMA50-0.48% SMA200-74.11% Volume328,199 Change-5.80%
Sep-14-21Initiated JMP Securities Mkt Outperform $14
Jul-30-21Initiated Cantor Fitzgerald Overweight $24
Nov-24-20Upgrade Raymond James Outperform → Strong Buy
Aug-10-20Initiated Alliance Global Partners Buy $27
Jul-21-20Initiated Raymond James Outperform $23
Jul-21-20Initiated BMO Capital Markets Outperform $30
Jul-21-20Initiated Barclays Overweight $22
Jan-24-23 07:00AM
Jan-03-23 07:00AM
Dec-12-22 07:00AM
Dec-09-22 04:01PM
Nov-29-22 07:00AM
07:00AM Loading…
Nov-09-22 07:00AM
Oct-26-22 07:00AM
Oct-20-22 07:09AM
Sep-28-22 08:57AM
Sep-19-22 07:00AM
Sep-12-22 07:00AM
Sep-06-22 03:25PM
Sep-02-22 10:04AM
Aug-31-22 09:55AM
09:40AM Loading…
Aug-30-22 07:00AM
Aug-15-22 12:00PM
Aug-10-22 07:00AM
Aug-03-22 07:00AM
Jul-27-22 07:00AM
Jul-25-22 07:00AM
Jul-05-22 07:00AM
Jun-15-22 07:00AM
Jun-06-22 07:00AM
Jun-02-22 07:00AM
Jun-01-22 07:00AM
May-31-22 07:00AM
May-23-22 12:04PM
07:00AM Loading…
May-16-22 09:55AM
May-11-22 07:00AM
Apr-27-22 07:00AM
Apr-25-22 07:30AM
Apr-12-22 08:00AM
Apr-06-22 07:00AM
Mar-28-22 02:11PM
Mar-08-22 07:00AM
Mar-02-22 07:00AM
Mar-01-22 07:00AM
Feb-09-22 07:00AM
Jan-26-22 07:30AM
Jan-04-22 07:30AM
Jan-03-22 07:30AM
Dec-27-21 09:22AM
Dec-14-21 03:26PM
Nov-18-21 07:00AM
Nov-16-21 10:20AM
Nov-10-21 07:00AM
Nov-01-21 07:00AM
Sep-27-21 02:08PM
Sep-20-21 07:00AM
Sep-13-21 11:00AM
Aug-17-21 08:00AM
Aug-11-21 07:00AM
Aug-09-21 08:00AM
Jul-28-21 07:00AM
Jul-12-21 08:00AM
Jun-28-21 09:30AM
Jun-23-21 06:30AM
Jun-22-21 09:58PM
Jun-02-21 09:10AM
May-19-21 12:51PM
May-12-21 07:00AM
Apr-29-21 07:00AM
Mar-29-21 08:33AM
Feb-23-21 07:30AM
Feb-16-21 07:31AM
Feb-10-21 07:34AM
Jan-27-21 07:30AM
Dec-22-20 07:00AM
Dec-16-20 07:00AM
Dec-03-20 08:00AM
Nov-24-20 08:17AM
Nov-11-20 06:30AM
Nov-04-20 08:45AM
Oct-28-20 07:00AM
Oct-14-20 10:29AM
Sep-28-20 01:28PM
Aug-19-20 07:00AM
Aug-05-20 04:01PM
Aug-03-20 07:00AM
Jul-27-20 07:00AM
Jul-01-20 09:00AM
Jun-30-20 04:01PM
Jun-26-20 02:04AM
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.